Weighing In on the Beneficial Effects of GLP-1 Agonists: Assessing Cardiovascular Risk Reduction, Combination Therapy and Adherence

Presented by Frank Lavernia, MD; Jack L. Leahy, MD; R. Daniel Pollom, MD; Carol H. Wysham, MD

This educational activity is intended for internists and other healthcare professionals involved in the treatment of patients with type 2 diabetes mellitus.

This activity has expired and is no longer valid for CME credit

Begin Presentation

To view audio/video presentations, you will need the latest version of Adobe Flash.